News and features
Read the latest news and features about our world-leading research, discoveries, fundraising and philanthropy. If you want to keep updated on our news, you can follow us on social media or sign up for our Search newsletter.
If you’re a journalist and want to find out more, you can contact our media relations team.
Blood test supports use of potential new treatment for patients with stomach cancer
Testing cancers for ‘addiction’ to a gene that boosts cell growth can pick out patients who may respond to a targeted drug under development, a major new study reports.
Top breast cancer scientist recognised by the Academy of Medical Sciences
Professor Clare Isacke has been elected to the Academy of Medical Sciences in recognition of her outstanding contribution to the advancement of cancer research.
Breast cancer can ‘reprogram’ its metabolism to resist hormone therapy
Cells from the most common form of breast cancer can reprogram their metabolism to help resist hormone treatments and become more aggressive, a new study shows.
New insights show how some breast cancers resist treatment
Breast cancer cells can become resistant to a common anticancer drug in a variety of different ways — suggesting that tailored treatment combinations to overcome resistance may be required for each patient.
New way of targeting cancer’s most commonly mutated gene
Blocking a gene involved with cellular division and replication could provide clues in understanding how to target the most common mutation found in cancer, a new study shows.
Gene may worsen cancer outcome by speeding metabolism of drugs
Some patients with breast cancer, lung cancer and leukaemia seem to fare poorly after treatment because of the effects of a particular gene, a new study finds.
Study reveals enzymes that cancers depend on to survive
A new study has identified a catalogue of specific enzymes, known as kinases, that some types of cancer rely on to survive.
Drug combination slows breast cancer spread
A combination of two drugs delays progression of advanced, aggressive breast cancer by an average of nine months – working in all subsets of the most common type of breast cancer, research has shown.
-and-actin-(green)-julia-sero-the-icr-2011.jpg?sfvrsn=14c02140_2 "Breast epithelial cells stained for DNA (magenta) and actin (green). Julia Sero / the ICR, 2011")
‘Ecologically diverse’ breast cancers more likely to be deadly
Breast cancers which are particularly complex and diverse, as judged by a test used in ecology to analyse species of animals and plants, are particularly likely to progress and lead to death, a new study shows.
Scientists identify protein used by breast tumours to ‘radicalise’ normal cells and spread cancer
Wnt7a protein found to be key "rallying call" secreted by aggressive tumours to help recruit non-cancerous fibroblasts and enable growth.
Blood test detects when hormone treatment for breast cancer stops working
Scientists have developed a highly sensitive blood test that can spot when breast cancers become resistant to standard hormone treatment, and have demonstrated that this test could guide further treatment.
New ‘mutation-tracking’ blood test could predict breast cancer relapse months in advance
Scientists have developed a blood test for breast cancer to spot patients will suffer a relapse after treatment, months before tumours are visible on hospital scans.
